Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Team Grant: Vision, Hearing and Communication Disorders - LOI

Université de Montréal

$5,000.00

CIHR Team Grant in "Saving Vision in Glaucoma: Novel Mechanisms and Therapeutic Targets."

EF 2009-10

Résumé
Glaucoma is a leading cause of blindness worldwide. In Canada alone, 1 in 100 persons over the age of 40 have glaucoma. Loss of vision in glaucoma is caused by the selective death of retinal ganglion cells (RGCs), the neurons that convey visual information from the retina to the brain. The mechanisms that lead to neuronal damage in glaucoma are not well understood, but reactive gliosis and excitotoxicity have been proposed to play major roles. In this application, we propose to tackle three broad questions; i) What is the role of reactive Mueller glia in glaucoma?, ii) How does the inflammatory cytokine Tumor Necrosis Factor-alpha kill RGCs?, and iii) How do calcium-permeable AMPA receptors mediate RGC loss in glaucoma? This research program will address novel mechanisms involved in RGC death that have not been previously examined. We will use a multidisciplinary approach to characterize distinct but interconnected cellular and molecular targets for glaucoma, namely the glial component, the mediators of death, and the killing mechanism. It is anticipated that this project will lead to clinically relevant insights on novel therapies for glaucoma.
Programme
Team Grant: Vision, Hearing and Communication Disorders - LOI
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
185655
Name
Di Polo Adriana
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Team Grant: Vision, Hearing and Communications Disorders
Projecttitle
CIHR Team Grant in "Saving Vision in Glaucoma: Novel Mechanisms and Therapeutic Targets."
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Team Grant: Vision, Hearing and Communication Disorders - LOI
Keyworddelim
Glaucoma; Glutamate Receptors; Mueller Glia; Nuclear Factor Kappa B; Retinal Ganglion Cell; Tumor Necrosis Factor
Abstract
Glaucoma is a leading cause of blindness worldwide. In Canada alone, 1 in 100 persons over the age of 40 have glaucoma. Loss of vision in glaucoma is caused by the selective death of retinal ganglion cells (RGCs), the neurons that convey visual information from the retina to the brain. The mechanisms that lead to neuronal damage in glaucoma are not well understood, but reactive gliosis and excitotoxicity have been proposed to play major roles. In this application, we propose to tackle three broad questions; i) What is the role of reactive Mueller glia in glaucoma?, ii) How does the inflammatory cytokine Tumor Necrosis Factor-alpha kill RGCs?, and iii) How do calcium-permeable AMPA receptors mediate RGC loss in glaucoma? This research program will address novel mechanisms involved in RGC death that have not been previously examined. We will use a multidisciplinary approach to characterize distinct but interconnected cellular and molecular targets for glaucoma, namely the glial component, the mediators of death, and the killing mechanism. It is anticipated that this project will lead to clinically relevant insights on novel therapies for glaucoma.
Competitiondate
200904
Approvedterm2
1 yr 0 mth
Pinamesdelim
Di Polo, Adriana; Barker, Philip A; Bowie, Derek
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $5,000~ $0~